* Misses main target in trial for early stage colon cancer * Success would have brought major boost for key Roche drug * Roche bought Genentech to benefit from Avastin sales * Roche shares fall...
WASHINGTON, Feb 24 - Millions of healthy men 55 and older should consider taking finasteride, a drug used to treat prostate enlargement symptoms and baldness, to prevent prostate cancer, two top U.S. medical groups said...
LEADING oncologists have called for cancer treatments to be independently reviewed to ensure toxic and expensive drugs are not being overused at patients' and taxpayers' expense...
* Denosumab is easier, less toxic and works better -expert * Can also ease emotional impact of devastating disease * High price likely, but fewer ancillary costs BERLIN, Sept 22 - Patients with breast cancer...
* Avastin improves patients daily lives, study finds * Patients may have better memory, less need for steroids BERLIN, Sept 22 - Roche's Avastin, which has already been shown to help patients with brain cancer...
* Shares surge almost 13 percent in after-hours trade * Denosumab reduces or delays bone complications * Infrequent jaw deterioration seen, similar to Zometa (Adds trial results details) NEW YORK, July 7 - Amgen Inc...
* BiPar/Sanofi drug boosts survival 60 pct * AstraZeneca's olaparib shrinks tumors in 1/3 of patients ORLANDO, Fla., May 31 - Drugs targeting an enzyme known as PARP show promise as treatments for some of...
* Alimta overall survival 13.4 months vs 10.6 on placebo * Benefit 15.5 months vs 10.3 in nonsquamous patients NEW YORK, May 30 - The use of Eli Lilly and Co's LLY.N Alimta following successful...
* Study shows 23 pct risk reduction with Avodart over 4 yrs * No significant increased incidence of severe tumour types * Glaxo shares extend gains to 8 percent in U.S. trade LONDON, April 27...
* Sutent study stopped after delayed progression seen * Patients taking placebos allowed to switch to Sutent * Pfizer shrs rise almost 10 percent, helped by drug study (Adds S&P sales forecast for Sutent, updates...